Stock page
Psyence Group Inc (PSYGF)
Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and support of mental wellness. It is involved in cultivating and exporting psilocybin mushrooms to the legal medical and research markets; developing drugs in the field of palliative care; and offering a range of non-psilocybin containing functional mushroom nutraceutical products called Goodmind, designed to enhance mental capacity and the body's ability to adapt to stress. The group operates in two segments: clinical trial activities and non-clinical trial activities. Geographically, it has a presence in Canada, the USA, Southern Africa, and the British Virgin Islands.
Quote snapshot
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|